High	O
frequency	O
of	O
germ-line	O
BRCA2	B-DNA
mutations	O
among	O
Hungarian	O
male	O
breast	O
cancer	O
patients	O
without	O
family	O
history	O
.	O

To	O
determine	O
the	O
contribution	O
of	O
BRCA1	B-DNA
and	O
BRCA2	B-DNA
mutations	O
to	O
the	O
pathogenesis	O
of	O
male	O
breast	O
cancer	O
in	O
Hungary	O
,	O
the	O
country	O
with	O
the	O
highest	O
male	O
breast	O
cancer	O
mortality	O
rates	O
in	O
continental	O
Europe	O
,	O
a	O
series	O
of	O
18	O
male	O
breast	O
cancer	O
patients	O
and	O
three	O
patients	O
with	O
gynecomastia	O
was	O
analyzed	O
for	O
germ-line	O
mutations	O
in	O
both	O
BRCA1	B-DNA
and	O
BRCA2	B-DNA
.	O

Although	O
no	O
germ-line	O
BRCA1	B-DNA
mutation	O
was	O
observed	O
,	O
6	O
of	O
the	O
18	O
male	O
breast	O
cancer	O
cases	O
(	O
33	O
%	O
)	O
carried	O
truncating	O
mutations	O
in	O
the	O
BRCA2	B-DNA
gene	O
.	O

Unexpectedly	O
,	O
none	O
of	O
them	O
reported	O
a	O
family	O
history	O
for	O
breast/ovarian	O
cancer	O
.	O

Four	O
of	O
six	O
truncating	O
mutations	O
were	O
novel	O
,	O
and	O
two	O
mutations	O
were	O
recurrent	O
.	O

Four	O
patients	O
(	O
22	O
%	O
)	O
had	O
a	O
family	O
history	O
of	O
breast/ovarian	O
cancer	O
in	O
at	O
least	O
one	O
first-	O
or	O
second-degree	O
relative	O
;	O
however	O
,	O
no	O
BRCA2	B-DNA
mutation	O
was	O
identified	O
among	O
them	O
.	O

No	O
mutation	O
was	O
identified	O
in	O
either	O
of	O
the	O
genes	O
in	O
the	O
gynecomastias	O
.	O

These	O
results	O
provide	O
evidence	O
for	O
a	O
strong	O
genetic	O
component	O
of	O
male	O
breast	O
cancer	O
in	O
Hungary	O
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
59	NULL
,	NULL
995-998	NULL
,	NULL
March	NULL
1	NULL
,	NULL
1999	NULL
]	NULL
Advances	NULL
in	NULL
Brief	NULL
High	NULL
Frequency	NULL
of	NULL
Germ-Line	NULL
BRCA2	NULL
Mutations	NULL
among	NULL
Hungarian	NULL
Male	NULL
Breast	NULL
Cancer	NULL
Patients	NULL
without	NULL
Family	NULL
History	NULL
'	NULL
Bela	NULL
Csokay	NULL
,	NULL
Nora	NULL
Udvarhelyi	NULL
,	NULL
Zoltan	NULL
Sulyok	NULL
,	NULL
Istvan	NULL
Besznyak	NULL
,	NULL
Susan	NULL
Ramus	NULL
,	NULL
Bruce	NULL
Ponder	NULL
,	NULL
and	NULL
Edith	NULL
Olah*	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Oncology	NULL
,	NULL
H-1525	NULL
Budapest	NULL
,	NULL
Hungary	NULL
[	NULL
B.C	NULL
.	NULL

,	NULL
N.U	NULL
.	NULL

,	NULL
Z.	NULL
S.	NULL
,	NULL
I	NULL
.	NULL

B	NULL
,	NULL
E.O	NULL
.	NULL
]	NULL

,	NULL
and	NULL
Strangeways	NULL
Research	NULL
Laboratories	NULL
,	NULL
Cambridge	NULL
CBI	NULL
SRN	NULL
,	NULL
United	NULL
Kingdom	NULL
[	NULL
S.	NULL
R.	NULL
,	NULL
B.	NULL
P.	NULL
]	NULL
Abstract	NULL
To	NULL
determine	NULL
the	NULL
contribution	NULL
of	NULL
BRCAI	NULL
and	NULL
BRCA2	NULL
mutations	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
in	NULL
Hungary	NULL
,	NULL
the	NULL
country	NULL
with	NULL
the	NULL
highest	NULL
male	NULL
breast	NULL
cancer	NULL
mortality	NULL
rates	NULL
in	NULL
continental	NULL
Europe	NULL
,	NULL
a	NULL
series	NULL
of	NULL
18	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
and	NULL
three	NULL
patients	NULL
with	NULL
gynecomastia	NULL
was	NULL
analyzed	NULL
for	NULL
germ-line	NULL
mutations	NULL
in	NULL
both	NULL
BRCAI	NULL
and	NULL
BRCA2	NULL
.	NULL

Although	NULL
no	NULL
germ-line	NULL
BRCAI	NULL
mutation	NULL
was	NULL
observed	NULL
,	NULL
6	NULL
of	NULL
the	NULL
18	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
(	NULL
33	NULL
%	NULL
)	NULL
carried	NULL
truncating	NULL
mutations	NULL
in	NULL
the	NULL
BRCA2	NULL
gene	NULL
.	NULL

Unexpectedly	NULL
,	NULL
none	NULL
of	NULL
them	NULL
reported	NULL
a	NULL
family	NULL
history	NULL
for	NULL
breast/	NULL
ovarian	NULL
cancer	NULL
.	NULL

Four	NULL
of	NULL
six	NULL
truncating	NULL
mutations	NULL
were	NULL
novel	NULL
,	NULL
and	NULL
two	NULL
mutations	NULL
were	NULL
recurrent	NULL
.	NULL

Four	NULL
patients	NULL
(	NULL
22	NULL
%	NULL
)	NULL
had	NULL
a	NULL
family	NULL
history	NULL
of	NULL
breast/ovarian	NULL
cancer	NULL
in	NULL
at	NULL
least	NULL
one	NULL
first-	NULL
or	NULL
second-degree	NULL
relative	NULL
;	NULL
however	NULL
,	NULL
no	NULL
BRCA2	NULL
mutation	NULL
was	NULL
identified	NULL
among	NULL
them	NULL
.	NULL

No	NULL
mutation	NULL
was	NULL
identified	NULL
in	NULL
either	NULL
of	NULL
the	NULL
genes	NULL
in	NULL
the	NULL
gynecomastias	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
strong	NULL
genetic	NULL
component	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
in	NULL
Hungary	NULL
.	NULL

Introduction	NULL
Male	NULL
breast	NULL
cancer	NULL
is	NULL
a	NULL
rare	NULL
disease	NULL
,	NULL
comprising	NULL
<	NULL
1	NULL
%	NULL
of	NULL
all	NULL
malignancies	NULL
in	NULL
men	NULL
in	NULL
the	NULL
western	NULL
world	NULL
;	NULL
however	NULL
,	NULL
in	NULL
some	NULL
developing	NULL
areas	NULL
,	NULL
it	NULL
is	NULL
more	NULL
frequent	NULL
,	NULL
accounting	NULL
for	NULL
6-15	NULL
%	NULL
of	NULL
all	NULL
breast	NULL
cancers	NULL
.	NULL
``	NULL

In	NULL
continental	NULL
Europe	NULL
,	NULL
the	NULL
Hungarians	NULL
have	NULL
the	NULL
highest	NULL
male	NULL
breast	NULL
cancer	NULL
mortality	NULL
rates	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
biggest	NULL
risk	NULL
factor	NULL
for	NULL
breast	NULL
cancer	NULL
in	NULL
both	NULL
genders	NULL
seems	NULL
to	NULL
be	NULL
inherited	NULL
predisposition	NULL
.	NULL

Approximately	NULL
5-10	NULL
%	NULL
of	NULL
female	NULL
breast	NULL
cancer	NULL
cases	NULL
are	NULL
due	NULL
to	NULL
inheritance	NULL
of	NULL
autosomal	NULL
dominant	NULL
susceptibility	NULL
genes	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
inherited	NULL
cases	NULL
,	NULL
the	NULL
recently	NULL
isolated	NULL
genes	NULL
BRCA	NULL
I	NULL
and	NULL
BRCAZ	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
disease	NULL
(	NULL
3	NULL
)	NULL
.	NULL

BRCA	NULL
!	NULL

is	NULL
estimated	NULL
to	NULL
account	NULL
for	NULL
most	NULL
female	NULL
breast/ovarian	NULL
cancer	NULL
families	NULL
,	NULL
but	NULL
it	NULL
can	NULL
be	NULL
infrequently	NULL
detected	NULL
in	NULL
families	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
.	NULL

However	NULL
,	NULL
breast	NULL
cancer-prone	NULL
families	NULL
in	NULL
whom	NULL
male	NULL
breast	NULL
cancer	NULL
occurred	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
linked	NULL
to	NULL
or	NULL
have	NULL
mutation	NULL
in	NULL
BRCAZ	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Our	NULL
earlier	NULL
results	NULL
did	NULL
not	NULL
reveal	NULL
BRCAZ	NULL
carrier	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
in	NULL
Hungarian	NULL
breast	NULL
cancer	NULL
families	NULL
,	NULL
but	NULL
two	NULL
individuals	NULL
without	NULL
family	NULL
history	NULL
were	NULL
found	NULL
to	NULL
carry	NULL
BRCAZ	NULL
mutations	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Very	NULL
little	NULL
is	NULL
yet	NULL
known	NULL
about	NULL
the	NULL
genetic	NULL
background	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

Somatic	NULL
mutations	NULL
of	NULL
the	NULL
p53	NULL
gene	NULL
were	NULL
identified	NULL
in	NULL
41	NULL
%	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
studied	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Defects	NULL
in	NULL
only	NULL
a	NULL
few	NULL
genes	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
predisposition	NULL
to	NULL
the	NULL
development	NULL
of	NULL
this	NULL
disease	NULL
.	NULL

Genetic	NULL
abnormalities	NULL
of	NULL
the	NULL
androgen	NULL
receptor	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
association	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
(	NULL
7	NULL
)	NULL
.	NULL

There	NULL
are	NULL
some	NULL
reports	NULL
of	NULL
mutation	NULL
involvement	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
Received	NULL
11/10/98	NULL
;	NULL
accepted	NULL
1/15/99	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

Supported	NULL
by	NULL
Hungarian	NULL
Research	NULL
Grants	NULL
OTKA	NULL
(	NULL
T19307	NULL
)	NULL
and	NULL
OMFB	NULL
(	NULL
EU	NULL
96-D9-004	NULL
;	NULL
to	NULL
E	NULL
.	NULL

O	NULL
.	NULL
)	NULL

and	NULL
a	NULL
program	NULL
grant	NULL
from	NULL
the	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
(	NULL
to	NULL
B.	NULL
P.	NULL
)	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Oncology	NULL
,	NULL
Rath	NULL
Gyorgy	NULL
Str	NULL
.	NULL

7-9	NULL
,	NULL
H-1525	NULL
Budapest	NULL
114	NULL
PF	NULL
.	NULL

21	NULL
,	NULL
Hungary	NULL
.	NULL

3	NULL
Breast	NULL
Cancer	NULL
in	NULL
Men	NULL
.	NULL

http	NULL
:	NULL
//interact.withus.com/interact/mbc/	NULL
.	NULL

995	NULL
(	NULL
8-10	NULL
)	NULL
,	NULL
but	NULL
in	NULL
all	NULL
cases	NULL
the	NULL
patients	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
were	NULL
members	NULL
of	NULL
families	NULL
carrying	NULL
BRCAI	NULL
mutation	NULL
.	NULL

There	NULL
is	NULL
much	NULL
more	NULL
evidence	NULL
that	NULL
inherited	NULL
BRCAZ	NULL
mutations	NULL
increase	NULL
the	NULL
risk	NULL
for	NULL
developing	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

Several	NULL
families	NULL
that	NULL
also	NULL
contained	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
were	NULL
reported	NULL
to	NULL
carry	NULL
BRCA2Z	NULL
mutations	NULL
(	NULL
4	NULL
,	NULL
11-13	NULL
)	NULL
.	NULL

Men	NULL
who	NULL
carry	NULL
a	NULL
germ-line	NULL
BRCAZ	NULL
mutation	NULL
have	NULL
an	NULL
increased	NULL
risk	NULL
of	NULL
breast	NULL
cancer	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Although	NULL
men	NULL
with	NULL
breast	NULL
cancer	NULL
also	NULL
often	NULL
have	NULL
gynecomastia	NULL
,	NULL
it	NULL
is	NULL
still	NULL
unknown	NULL
whether	NULL
gynecomastia	NULL
per	NULL
se	NULL
predisposes	NULL
the	NULL
male	NULL
breast	NULL
to	NULL
malignant	NULL
disease	NULL
.	NULL

Some	NULL
authors	NULL
report	NULL
that	NULL
as	NULL
many	NULL
as	NULL
20-36	NULL
%	NULL
of	NULL
the	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
in	NULL
their	NULL
studies	NULL
have	NULL
a	NULL
history	NULL
of	NULL
gynecomastia	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
contribution	NULL
of	NULL
germline	NULL
mutations	NULL
in	NULL
the	NULL
BRCAI	NULL
and	NULL
BRCAZ	NULL
genes	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
in	NULL
Hungary	NULL
by	NULL
screening	NULL
a	NULL
series	NULL
of	NULL
18	NULL
unselected	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
and	NULL
three	NULL
patients	NULL
with	NULL
gynecomastia	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Patients	NULL
.	NULL

Blood	NULL
samples	NULL
were	NULL
collected	NULL
from	NULL
all	NULL
consenting	NULL
patients	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
or	NULL
gynecomastia	NULL
at	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Oncology	NULL
(	NULL
Budapest	NULL
,	NULL
Hungary	NULL
)	NULL
in	NULL
the	NULL
period	NULL
of	NULL
1996-1998	NULL
.	NULL

The	NULL
histopathological	NULL
typing	NULL
of	NULL
the	NULL
cases	NULL
was	NULL
completed	NULL
by	NULL
board-certified	NULL
pathologists	NULL
.	NULL

This	NULL
panel	NULL
represents	NULL
consecutive	NULL
cases	NULL
who	NULL
were	NULL
not	NULL
selected	NULL
for	NULL
family	NULL
history	NULL
of	NULL
breast/	NULL
ovarian	NULL
cancer	NULL
;	NULL
however	NULL
,	NULL
information	NULL
on	NULL
family	NULL
history	NULL
was	NULL
available	NULL
for	NULL
all	NULL
patients	NULL
.	NULL

The	NULL
patients	NULL
with	NULL
gynecomastia	NULL
did	NULL
not	NULL
have	NULL
a	NULL
medical	NULL
history	NULL
of	NULL
Klinefelter	NULL
syndrome	NULL
.	NULL

BRCA1	NULL
and	NULL
BRCA	NULL
Mutation	NULL
Screening	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
extracted	NULL
by	NULL
standard	NULL
methods	NULL
from	NULL
peripheral	NULL
lymphocytes	NULL
from	NULL
all	NULL
patients	NULL
.	NULL

PCR	NULL
amplification	NULL
of	NULL
160-550-bp	NULL
DNA	NULL
fragments	NULL
covering	NULL
the	NULL
entire	NULL
BRCA2	NULL
coding	NULL
region	NULL
and	NULL
splice	NULL
junctions	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
a	NULL
set	NULL
of	NULL
44	NULL
primer	NULL
pairs	NULL
(	NULL
5	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
all	NULL
exons	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
exon	NULL
11	NULL
were	NULL
amplified	NULL
with	NULL
a	NULL
set	NULL
of	NULL
23	NULL
primer	NULL
pairs	NULL
;	NULL
exon	NULL
11	NULL
was	NULL
screened	NULL
in	NULL
three	NULL
overlapping	NULL
protein	NULL
truncation	NULL
test	NULL
fragments	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Mu-tational	NULL
screening	NULL
was	NULL
performed	NULL
in	NULL
germ-line	NULL
DNA	NULL
by	NULL
combined	NULL
multiple	NULL
heteroduplex	NULL
analysis	NULL
and/or	NULL
by	NULL
single	NULL
strand	NULL
conformation	NULL
analysis	NULL
.	NULL

Mutation	NULL
screening	NULL
in	NULL
both	NULL
genes	NULL
was	NULL
performed	NULL
irrespective	NULL
of	NULL
identification	NULL
of	NULL
a	NULL
mutation	NULL
in	NULL
one	NULL
gene	NULL
,	NULL
because	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
mutations	NULL
of	NULL
both	NULL
BRCA	NULL
]	NULL
and	NULL
BRCA2	NULL
may	NULL
be	NULL
segregating	NULL
in	NULL
a	NULL
family	NULL
,	NULL
as	NULL
we	NULL
reported	NULL
in	NULL
a	NULL
Hungarian	NULL
breast/ovarian	NULL
cancer	NULL
patient	NULL
(	NULL
17	NULL
)	NULL
.	NULL

PCR	NULL
products	NULL
from	NULL
variant	NULL
conformers	NULL
were	NULL
purified	NULL
using	NULL
Wizard	NULL
PCR	NULL
Prep	NULL
DNA	NULL
Purification	NULL
System	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
and	NULL
sequenced	NULL
using	NULL
the	NULL
Thermosequenase	NULL
Cyclo	NULL
Sequencing	NULL
kit	NULL
(	NULL
USB-Am-ersham	NULL
)	NULL
.	NULL

Results	NULL
The	NULL
entire	NULL
coding	NULL
regions	NULL
and	NULL
intronic	NULL
splice	NULL
sites	NULL
of	NULL
both	NULL
BRCALI	NULL
and	NULL
BRCA2	NULL
were	NULL
screened	NULL
using	NULL
multiple	NULL
heteroduplex	NULL
analysis/single-strand	NULL
conformation	NULL
analysis	NULL
and	NULL
protein	NULL
truncation	NULL
test	NULL
,	NULL
followed	NULL
by	NULL
direct	NULL
sequencing	NULL
of	NULL
abnormalities	NULL
.	NULL

Six	NULL
of	NULL
the	NULL
18	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
(	NULL
33	NULL
%	NULL
)	NULL
were	NULL
observed	NULL
to	NULL
carry	NULL
truncating	NULL
mutations	NULL
in	NULL
the	NULL
BRCAZ	NULL
gene	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
six	NULL
truncating	NULL
mutations	NULL
were	NULL
novel	NULL
;	NULL
the	NULL
other	NULL
two	NULL
alterations	NULL
(	NULL
277delAC	NULL
and	NULL
9326insA	NULL
)	NULL
were	NULL
reported	NULL
earlier	NULL
(	NULL
5	NULL
,	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

A	NULL
review	NULL
was	NULL
conducted	NULL
of	NULL
the	NULL
clinical	NULL
and	NULL
family	NULL
history	NULL
of	NULL
the	NULL
mutation	NULL
carriers	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GERM-LINE	NULL
BRCA2	NULL
MUTATIONS	NULL
IN	NULL
MALE	NULL
BREAST	NULL
CANCER	NULL
Table	NULL
1	NULL
Germ-line	NULL
BRCA2	NULL
mutations	NULL
in	NULL
Hungarian	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
Patient	NULL
Mutation	NULL
Codon	NULL
Nucleotide	NULL
Exon	NULL
Effect	NULL
Stop	NULL
codon	NULL
BIC	NULL
``	NULL
MBC-2	NULL
4232ins	NULL
A	NULL
1335	NULL
4232	NULL
11	NULL
Frameshift	NULL
1337	NULL
,	NULL
ex	NULL
11	NULL
Not	NULL
reported	NULL
MBC-3	NULL
277delAC	NULL
17	NULL
277	NULL
2	NULL
Frameshift	NULL
29	NULL
,	NULL
ex	NULL
3	NULL
Reported	NULL
3	NULL
times	NULL
MBC-9	NULL
3868insT	NULL
1214	NULL
3868	NULL
11	NULL
Frameshift	NULL
1217	NULL
,	NULL
ex	NULL
11	NULL
Not	NULL
reported	NULL
MBC-15	NULL
7979delG	NULL
2584	NULL
7979	NULL
16	NULL
Frameshift	NULL
2647	NULL
,	NULL
ex	NULL
17	NULL
Not	NULL
reported	NULL
MBC-19	NULL
841insCTTA	NULL
205	NULL
841	NULL
7	NULL
Frameshift	NULL
215	NULL
,	NULL
ex	NULL
8	NULL
Not	NULL
reported	NULL
MBC-22	NULL
9326insA	NULL
3033	NULL
9326	NULL
23	NULL
Frameshift	NULL
3043	NULL
,	NULL
ex	NULL
24	NULL
Reported	NULL
3	NULL
times	NULL
``	NULL
BIC	NULL
,	NULL
Breast	NULL
Cancer	NULL
Information	NULL
Core	NULL
,	NULL
November	NULL
1	NULL
,	NULL
1998	NULL
;	NULL
MBC	NULL
,	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

None	NULL
of	NULL
them	NULL
reported	NULL
a	NULL
family	NULL
history	NULL
for	NULL
breast/ovarian	NULL
cancer	NULL
.	NULL

Two	NULL
patients	NULL
(	NULL
11	NULL
%	NULL
)	NULL
had	NULL
a	NULL
family	NULL
history	NULL
of	NULL
breast/ovarian	NULL
cancer	NULL
in	NULL
at	NULL
least	NULL
one	NULL
first-degree	NULL
relative	NULL
and	NULL
another	NULL
two	NULL
(	NULL
11	NULL
%	NULL
)	NULL
in	NULL
at	NULL
least	NULL
one	NULL
second-degree	NULL
relative	NULL
in	NULL
this	NULL
unselected	NULL
study	NULL
;	NULL
however	NULL
,	NULL
no	NULL
BRCA2	NULL
mutation	NULL
was	NULL
observed	NULL
among	NULL
them	NULL
.	NULL

No	NULL
germ-line	NULL
BRCAI	NULL
mutations	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
,	NULL
nor	NULL
was	NULL
a	NULL
mutation	NULL
identified	NULL
in	NULL
either	NULL
BRCALI	NULL
or	NULL
BRCAZ	NULL
in	NULL
the	NULL
three	NULL
cases	NULL
of	NULL
gynecomastia	NULL
;	NULL
however	NULL
,	NULL
one	NULL
patient	NULL
(	NULL
G2	NULL
)	NULL
from	NULL
this	NULL
group	NULL
carried	NULL
an	NULL
unclassified	NULL
BRCAZ	NULL
variant	NULL
allele	NULL
with	NULL
unclear	NULL
significance	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
between	NULL
mutation	NULL
carriers	NULL
and	NULL
noncarriers	NULL
with	NULL
respect	NULL
to	NULL
clinicopathological	NULL
features	NULL
nor	NULL
age	NULL
at	NULL
diagnosis	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

The	NULL
average	NULL
age	NULL
at	NULL
diagnosis	NULL
was	NULL
62	NULL
years	NULL
;	NULL
there	NULL
was	NULL
only	NULL
an	NULL
insignificant	NULL
difference	NULL
between	NULL
the	NULL
mean	NULL
age	NULL
of	NULL
onset	NULL
of	NULL
carriers	NULL
(	NULL
58	NULL
years	NULL
)	NULL
and	NULL
noncarriers	NULL
(	NULL
64	NULL
years	NULL
)	NULL
.	NULL

Discussion	NULL
In	NULL
the	NULL
first	NULL
studies	NULL
of	NULL
BRCAZ	NULL
analysis	NULL
(	NULL
4	NULL
,	NULL
11	NULL
)	NULL
,	NULL
the	NULL
subjects	NULL
of	NULL
scrutiny	NULL
were	NULL
mostly	NULL
large	NULL
families	NULL
that	NULL
sometimes	NULL
also	NULL
contained	NULL
members	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

In	NULL
more	NULL
recent	NULL
reports	NULL
(	NULL
20-22	NULL
)	NULL
,	NULL
sets	NULL
of	NULL
population-based	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
were	NULL
studied	NULL
for	NULL
the	NULL
frequency	NULL
of	NULL
germ-line	NULL
BRCAZ	NULL
carriers	NULL
.	NULL

Here	NULL
we	NULL
analyzed	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
from	NULL
a	NULL
hospital-based	NULL
study	NULL
to	NULL
determine	NULL
the	NULL
contribution	NULL
of	NULL
BRCAL	NULL
and	NULL
BRCAZ	NULL
mutations	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
in	NULL
Hungary	NULL
.	NULL

Frequencies	NULL
reported	NULL
of	NULL
BRCAZ	NULL
mutations	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
vary	NULL
between	NULL
4	NULL
%	NULL
(	NULL
21	NULL
)	NULL
and	NULL
40	NULL
%	NULL
(	NULL
23	NULL
)	NULL
,	NULL
the	NULL
latter	NULL
results	NULL
are	NULL
possibly	NULL
influenced	NULL
by	NULL
a	NULL
strong	NULL
founder	NULL
effect	NULL
in	NULL
that	NULL
particular	NULL
population	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
reports	NULL
by	NULL
Friedman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
and	NULL
Mavraki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
,	NULL
who	NULL
found	NULL
4	NULL
and	NULL
7	NULL
%	NULL
of	NULL
patients	NULL
carrying	NULL
germ-line	NULL
BRCAZ	NULL
mutations	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
a	NULL
large	NULL
proportion	NULL
of	NULL
cases	NULL
was	NULL
found	NULL
to	NULL
carry	NULL
BRCA2Z	NULL
mutations	NULL
(	NULL
6	NULL
of	NULL
18	NULL
;	NULL
33	NULL
%	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
even	NULL
higher	NULL
than	NULL
the	NULL
recent	NULL
reports	NULL
of	NULL
Haraldsson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
,	NULL
who	NULL
identified	NULL
21	NULL
%	NULL
of	NULL
all	NULL
cases	NULL
to	NULL
be	NULL
BRCA2	NULL
mutation	NULL
carriers	NULL
.	NULL

Although	NULL
in	NULL
some	NULL
large	NULL
BRCA	NULL
]	NULL
families	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
germ-line	NULL
BRCAI	NULL
mutations	NULL
(	NULL
8-10	NULL
)	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
as	NULL
in	NULL
the	NULL
study	NULL
of	NULL
Friedman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
,	NULL
no	NULL
BRCAI	NULL
mutations	NULL
were	NULL
found	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
BRCA	NULL
J	NULL
germ-line	NULL
mutations	NULL
do	NULL
not	NULL
contribute	NULL
substantially	NULL
to	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
six	NULL
BRCAZ	NULL
mutations	NULL
were	NULL
identified	NULL
among	NULL
the	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
.	NULL

The	NULL
mutations	NULL
were	NULL
all	NULL
frameshifts	NULL
predicted	NULL
to	NULL
result	NULL
in	NULL
truncated	NULL
proteins	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
findings	NULL
,	NULL
that	NULL
>	NULL
85	NULL
%	NULL
of	NULL
BRCA	NULL
mutations	NULL
identified	NULL
cause	NULL
protein	NULL
truncation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Four	NULL
of	NULL
six	NULL
truncating	NULL
mutations	NULL
were	NULL
novel	NULL
;	NULL
the	NULL
other	NULL
two	NULL
alterations	NULL
have	NULL
been	NULL
reported	NULL
earlier	NULL
.	NULL

The	NULL
277delAC	NULL
mutation	NULL
was	NULL
reported	NULL
from	NULL
the	NULL
United	NULL
States	NULL
in	NULL
a	NULL
large	NULL
family	NULL
that	NULL
also	NULL
contained	NULL
three	NULL
cases	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
other	NULL
recurrent	NULL
mutation	NULL
(	NULL
9326insA	NULL
)	NULL
was	NULL
first	NULL
identified	NULL
in	NULL
Hungary	NULL
(	NULL
5	NULL
)	NULL
and	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
in	NULL
a	NULL
Hungarian	NULL
male	NULL
breast	NULL
cancer	NULL
patient	NULL
living	NULL
in	NULL
Sweden	NULL
(	NULL
22	NULL
)	NULL
and	NULL
in	NULL
a	NULL
French	NULL
breast-ovarian	NULL
cancer	NULL
family	NULL
that	NULL
did	NULL
not	NULL
contain	NULL
male	NULL
breast	NULL
cancer	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Several	NULL
additional	NULL
Hungarian	NULL
breast	NULL
cancer	NULL
families	NULL
were	NULL
identified	NULL
to	NULL
carry	NULL
9326insA	NULL
,	NULL
all	NULL
without	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
.	NULL

*	NULL
In	NULL
a	NULL
recent	NULL
international	NULL
collaborative	NULL
study	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
common	NULL
founding	NULL
haplotype	NULL
for	NULL
this	NULL
mutation	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
indication	NULL
for	NULL
a	NULL
common	NULL
origin	NULL
of	NULL
9326insA	NULL
from	NULL
the	NULL
Central-Eastern	NULL
European	NULL
region	NULL
.	NULL
``	NULL

The	NULL
mutations	NULL
we	NULL
found	NULL
in	NULL
this	NULL
study	NULL
are	NULL
located	NULL
in	NULL
exons	NULL
2	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
16	NULL
,	NULL
and	NULL
23	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
is	NULL
not	NULL
notably	NULL
different	NULL
from	NULL
the	NULL
distribution	NULL
of	NULL
either	NULL
BRCAZ	NULL
mutation	NULL
spectra	NULL
in	NULL
male	NULL
breast	NULL
cancers	NULL
from	NULL
other	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
or	NULL
of	NULL
all	NULL
BRCA2	NULL
mutations	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
to	NULL
date	NULL
that	NULL
mutations	NULL
in	NULL
specific	NULL
domains	NULL
of	NULL
BRCAZ	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

The	NULL
18	NULL
breast	NULL
cancer	NULL
patients	NULL
screened	NULL
for	NULL
germ-line	NULL
BRCA	NULL
mutations	NULL
were	NULL
selected	NULL
without	NULL
any	NULL
regard	NULL
for	NULL
family	NULL
history	NULL
.	NULL

However	NULL
,	NULL
information	NULL
on	NULL
family	NULL
history	NULL
was	NULL
available	NULL
for	NULL
all	NULL
patients	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
proportion	NULL
of	NULL
patients	NULL
with	NULL
family	NULL
history	NULL
of	NULL
breast/ovarian	NULL
cancer	NULL
in	NULL
at	NULL
least	NULL
one	NULL
first-degree	NULL
relative	NULL
was	NULL
11	NULL
%	NULL
(	NULL
2	NULL
of	NULL
18	NULL
)	NULL
,	NULL
and	NULL
in	NULL
at	NULL
least	NULL
one	NULL
second-degree	NULL
relative	NULL
,	NULL
also	NULL
11	NULL
%	NULL
(	NULL
2/18	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
studies	NULL
of	NULL
Rosenblatt	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
and	NULL
Friedman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
,	NULL
who	NULL
found	NULL
similar	NULL
proportions	NULL
in	NULL
their	NULL
studies	NULL
(	NULL
18-10	NULL
%	NULL
and	NULL
17-13	NULL
%	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
no	NULL
BRCAZ2	NULL
mutation	NULL
was	NULL
identified	NULL
among	NULL
the	NULL
cases	NULL
with	NULL
family	NULL
history	NULL
;	NULL
neither	NULL
did	NULL
the	NULL
mutation	NULL
carriers	NULL
report	NULL
family	NULL
histories	NULL
of	NULL
breast/ovarian	NULL
cancer	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
with	NULL
the	NULL
results	NULL
of	NULL
Couch	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
,	NULL
who	NULL
identified	NULL
germ-line	NULL
BRCAZ	NULL
mutations	NULL
in	NULL
7	NULL
of	NULL
50	NULL
(	NULL
14	NULL
%	NULL
)	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
,	NULL
6	NULL
of	NULL
7	NULL
(	NULL
85	NULL
%	NULL
)	NULL
of	NULL
whom	NULL
had	NULL
a	NULL
family	NULL
history	NULL
of	NULL
breast	NULL
cancer	NULL
.	NULL

Friedman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
found	NULL
two	NULL
mutation	NULL
carriers	NULL
in	NULL
their	NULL
panel	NULL
,	NULL
one	NULL
of	NULL
whom	NULL
had	NULL
a	NULL
family	NULL
history	NULL
.	NULL

Similarly	NULL
to	NULL
our	NULL
results	NULL
,	NULL
Haraldsson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
reported	NULL
recently	NULL
that	NULL
only	NULL
one	NULL
of	NULL
seven	NULL
BRCA2Z	NULL
mutation	NULL
carriers	NULL
had	NULL
a	NULL
positive	NULL
family	NULL
history	NULL
of	NULL
breast	NULL
cancer	NULL
.	NULL

No	NULL
evidence	NULL
for	NULL
differences	NULL
in	NULL
clinicopathological	NULL
features	NULL
was	NULL
seen	NULL
between	NULL
mutation	NULL
carriers	NULL
and	NULL
noncarriers	NULL
.	NULL

Most	NULL
patients	NULL
had	NULL
invasive	NULL
ductal	NULL
carcinoma	NULL
(	NULL
17	NULL
of	NULL
18	NULL
;	NULL
95	NULL
%	NULL
)	NULL
,	NULL
including	NULL
all	NULL
germ-line	NULL
BRCA2	NULL
mutation	NULL
carriers	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
literature	NULL
data	NULL
that	NULL
invasive	NULL
ductal	NULL
carcinomas	NULL
account	NULL
for	NULL
84-93	NULL
%	NULL
of	NULL
cases	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
average	NULL
age	NULL
of	NULL
men	NULL
at	NULL
diagnosis	NULL
of	NULL
breast	NULL
cancer	NULL
is	NULL
close	NULL
to	NULL
65	NULL
,	NULL
about	NULL
5	NULL
years	NULL
older	NULL
than	NULL
the	NULL
average	NULL
age	NULL
for	NULL
women	NULL
.	NULL
``	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
the	NULL
average	NULL
age	NULL
at	NULL
diagnosis	NULL
in	NULL
carriers	NULL
was	NULL
not	NULL
significantly	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
noncarriers	NULL
.	NULL

Compared	NULL
with	NULL
other	NULL
BRCAZ	NULL
mutations	NULL
,	NULL
9326insA	NULL
appears	NULL
to	NULL
be	NULL
linked	NULL
with	NULL
younger	NULL
age	NULL
of	NULL
onset	NULL
in	NULL
female	NULL
breast	NULL
cancer	NULL
(	NULL
26	NULL
)	NULL
and	NULL
possibly	NULL
also	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
(	NULL
22	NULL
)	NULL
.	NULL

No	NULL
mutation	NULL
was	NULL
identified	NULL
in	NULL
either	NULL
of	NULL
the	NULL
genes	NULL
in	NULL
the	NULL
three	NULL
cases	NULL
of	NULL
gynecomastia	NULL
;	NULL
however	NULL
,	NULL
one	NULL
patient	NULL
(	NULL
G2	NULL
)	NULL
from	NULL
this	NULL
group	NULL
carried	NULL
a	NULL
missense	NULL
BRCAZ	NULL
variant	NULL
allele	NULL
(	NULL
7O81A-G	NULL
)	NULL
with	NULL
unclear	NULL
signifi-cance	NULL
.	NULL

This	NULL
alteration	NULL
was	NULL
reported	NULL
eight	NULL
times	NULL
in	NULL
the	NULL
Breast	NULL
Cancer	NULL
Information	NULL
Core	NULL
as	NULL
an	NULL
unclassified	NULL
variant	NULL
and	NULL
lies	NULL
in	NULL
a	NULL
conserved	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
human	NULL
,	NULL
rat	NULL
,	NULL
and	NULL
mouse	NULL
;	NULL
however	NULL
,	NULL
expression	NULL
analysis	NULL
would	NULL
be	NULL
required	NULL
to	NULL
elucidate	NULL
the	NULL
nature	NULL
of	NULL
this	NULL
type	NULL
of	NULL
alteration	NULL
.	NULL

*	NULL
Unpublished	NULL
data	NULL
.	NULL

5	NULL
E.	NULL
Olah	NULL
et	NULL
al	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

©	NULL
Breast	NULL
Cancer	NULL
Information	NULL
Core	NULL
.	NULL

http	NULL
:	NULL
/www.nhgrinih.gov/Intramural_research/	NULL
Lab_transfer/Bic/	NULL
.	NULL

996	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GERM-LINE	NULL
BRCA2	NULL
MUTATIONS	NULL
IN	NULL
MALE	NULL
BREAST	NULL
CANCER	NULL
Table	NULL
2	NULL
BRCA2	NULL
polymorphisms	NULL
and	NULL
unclassified	NULL
variants	NULL
Patient	NULL
Variant	NULL
Codon	NULL
Exon	NULL
Effect	NULL
BIC	NULL
Comment	NULL
MBC*-10	NULL
5972	NULL
CIT	NULL
Thr1915Met	NULL
11	NULL
Missense	NULL
Reported	NULL
1	NULL
time	NULL
(	NULL
6	NULL
%	NULL
)	NULL
Frequent	NULL
polymorphism	NULL
MBC-14	NULL
,	NULL
15	NULL
IVS11	NULL
+	NULL
79del4	NULL
``	NULL
Intron	NULL
11	NULL
None	NULL
Reported	NULL
1	NULL
time	NULL
(	NULL
28	NULL
%	NULL
)	NULL
Frequent	NULL
polymorphism	NULL
7081	NULL
A/G	NULL
Ie2285Val	NULL
12	NULL
Missense	NULL
Reported	NULL
8	NULL
times	NULL
Rare	NULL
polymorphism	NULL
``	NULL
MBC	NULL
,	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

h	NULL
IVS	NULL
,	NULL
intronic	NULL
variant	NULL
.	NULL

©	NULL
G	NULL
,	NULL
Gynecomastia	NULL
.	NULL

5	NULL
18	NULL
|	NULL
20	NULL
4	NULL
6	NULL
17	NULL
21	NULL
16	NULL
22	NULL
3	NULL
7	NULL
15	NULL
8	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

BRCA2	NULL
mutation	NULL
spectrum	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
.	NULL

A	NULL
,	NULL
mutations	NULL
found	NULL
in	NULL
this	NULL
study	NULL
(	NULL
exons	NULL
2	NULL
,	NULL
11	NULL
,	NULL
10	NULL
16	NULL
,	NULL
and	NULL
23	NULL
)	NULL
.	NULL

A	NULL
,	NULL
mutations	NULL
found	NULL
by	NULL
Wooster	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
4	NULL
)	NULL
;	NULL
Couch	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
;	NULL
Phelan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
;	NULL
Tavtigian	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
;	NULL
i	NULL
;	NULL
11	NULL
27	NULL
Thorlacius	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
;	NULL
Friedman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
;	NULL
Mavraki	NULL
et	NULL
al	NULL
.	NULL

‘	NULL
l	NULL
(	NULL
20	NULL
)	NULL
;	NULL
Serova	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
;	NULL
and	NULL
Haraldsson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
.	NULL

Only	NULL
names	NULL
of	NULL
recurrent	NULL
mutations	NULL
are	NULL
indicated	NULL
.	NULL

A	NULL
A	NULL
277delAC	NULL
999del5	NULL
The	NULL
data	NULL
presented	NULL
here	NULL
imply	NULL
that	NULL
germ-line	NULL
mutations	NULL
in	NULL
the	NULL
BRCAZ2	NULL
gene	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
development	NULL
of	NULL
one-third	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
in	NULL
Hungary	NULL
.	NULL

There	NULL
may	NULL
be	NULL
other	NULL
genetic	NULL
factors	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
some	NULL
of	NULL
the	NULL
male	NULL
breast	NULL
cancers	NULL
that	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
mutations	NULL
in	NULL
the	NULL
BRCAZ	NULL
gene	NULL
.	NULL

There	NULL
is	NULL
no	NULL
evidence	NULL
for	NULL
a	NULL
male	NULL
breast	NULL
cancer-specific	NULL
cluster	NULL
region	NULL
in	NULL
the	NULL
BRCAZ	NULL
gene	NULL
thus	NULL
far	NULL
,	NULL
but	NULL
because	NULL
the	NULL
majority	NULL
of	NULL
BRCA2Z	NULL
mutations	NULL
found	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
are	NULL
unique	NULL
and	NULL
not	NULL
identified	NULL
in	NULL
female	NULL
breast	NULL
cancer	NULL
cases	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
at	NULL
least	NULL
some	NULL
BRCA2	NULL
mutations	NULL
may	NULL
predispose	NULL
to	NULL
male	NULL
rather	NULL
than	NULL
female	NULL
breast	NULL
cancer	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
certain	NULL
mutations	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
9326insA	NULL
)	NULL
result	NULL
in	NULL
both	NULL
male	NULL
and	NULL
female	NULL
breast	NULL
cancers	NULL
and	NULL
can	NULL
be	NULL
associated	NULL
with	NULL
various	NULL
phenotypes	NULL
in	NULL
different	NULL
families	NULL
.	NULL

This	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
mod	NULL
9326insA	NULL
4486delG	NULL
6174delT	NULL
ifying	NULL
factors	NULL
in	NULL
disease	NULL
development	NULL
different	NULL
in	NULL
males	NULL
and	NULL
fe-males	NULL
.	NULL

The	NULL
first	NULL
evidence	NULL
of	NULL
a	NULL
modifying	NULL
genetic	NULL
factor	NULL
of	NULL
BRCAZ	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
was	NULL
provided	NULL
recently	NULL
(	NULL
27	NULL
)	NULL
,	NULL
reporting	NULL
that	NULL
an	NULL
interstitial	NULL
tandem	NULL
duplication	NULL
on	NULL
9p	NULL
increases	NULL
the	NULL
risk	NULL
of	NULL
breast	NULL
cancer	NULL
in	NULL
male	NULL
patients	NULL
conferred	NULL
by	NULL
BRCAZ	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
a	NULL
positive	NULL
family	NULL
history	NULL
in	NULL
all	NULL
carriers	NULL
suggests	NULL
that	NULL
at	NULL
least	NULL
some	NULL
BRCA2	NULL
mutations	NULL
may	NULL
have	NULL
a	NULL
lower	NULL
penetrance	NULL
than	NULL
others	NULL
,	NULL
and	NULL
selection	NULL
of	NULL
putative	NULL
BRCAZ	NULL
mutation	NULL
carriers	NULL
among	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
can	NULL
not	NULL
be	NULL
based	NULL
on	NULL
the	NULL
family	NULL
background	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

Our	NULL
data	NULL
provide	NULL
further	NULL
evidence	NULL
that	NULL
in	NULL
certain	NULL
populations	NULL
there	NULL
is	NULL
a	NULL
high	NULL
genetic	NULL
component	NULL
in	NULL
the	NULL
development	NULL
of	NULL
this	NULL
disease	NULL
,	NULL
and	NULL
in	NULL
these	NULL
populations	NULL
all	NULL
patients	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
,	NULL
regardless	NULL
of	NULL
their	NULL
family	NULL
history	NULL
,	NULL
should	NULL
be	NULL
screened	NULL
for	NULL
BRCAZ	NULL
mutations	NULL
.	NULL

Table	NULL
3	NULL
Clinicopathological	NULL
characteristics	NULL
of	NULL
patients	NULL
tested	NULL
in	NULL
this	NULL
study	NULL
Patient	NULL
BRCA2	NULL
mutation	NULL
Phenotype	NULL
of	NULL
individual	NULL
Age	NULL
at	NULL
diagnosis	NULL
Family	NULL
history	NULL
of	NULL
cancer	NULL
MBC*-1	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
80	NULL
Negative	NULL
MBC-2	NULL
4232insA	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
60	NULL
Negative	NULL
MBC-3	NULL
277delAC	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
75	NULL
Negative	NULL
MBC-5	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
61	NULL
Negative	NULL
MBC-6	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
79	NULL
Negative	NULL
MBC-7	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
66	NULL
Grandfather	NULL
:	NULL
stomach	NULL
,	NULL
prostate	NULL
MBC-8	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
63	NULL
Negative	NULL
MBC-9	NULL
3868insT	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
68	NULL
Negative	NULL
MBC-10	NULL
No	NULL
Tubular	NULL
adenocarcinoma	NULL
62	NULL
Negative	NULL
MBC-12	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
46	NULL
Negative	NULL
MBC-13	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
85	NULL
Daughter	NULL
:	NULL
breast	NULL
;	NULL
Sister	NULL
:	NULL
ovary	NULL
MBC-14	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
77	NULL
Negative	NULL
MBC-15	NULL
7979delG	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
46	NULL
Grandmother	NULL
:	NULL
lung	NULL
MBC-17	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
49	NULL
Aunt	NULL
:	NULL
breast	NULL
;	NULL
Cousin	NULL
:	NULL
brain	NULL
MBC-19	NULL
841insCTTA	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
52	NULL
Father	NULL
:	NULL
stomach	NULL
;	NULL
Grandmother	NULL
:	NULL
lymphoma	NULL
MBC-20	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
53	NULL
Mother	NULL
:	NULL
breast	NULL
;	NULL
Aunt	NULL
:	NULL
ovary	NULL
MBC-21	NULL
No	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
48	NULL
Cousin	NULL
:	NULL
bilateral	NULL
breast	NULL
MBC-22	NULL
9326insA	NULL
Inv	NULL
.	NULL

ductal	NULL
carcinoma	NULL
48	NULL
Negative	NULL
G1	NULL
No	NULL
Gynecomastia	NULL
84	NULL
Negative	NULL
G2	NULL
7081A	NULL
>	NULL
G	NULL
Gynecomastia	NULL
21	NULL
Negative	NULL
G3	NULL
No	NULL
Gynecomastia	NULL
40	NULL
Mother	NULL
:	NULL
uterus	NULL
;	NULL
Sister	NULL
:	NULL
colon	NULL
;	NULL
Aunt	NULL
:	NULL
colon	NULL
``	NULL
MBC	NULL
,	NULL
male	NULL
breast	NULL
cancer	NULL
;	NULL
Inv	NULL
.	NULL

,	NULL
invasive	NULL
.	NULL

997	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GERM-LINE	NULL
BRCA2	NULL
MUTATIONS	NULL
IN	NULL
MALE	NULL
BREAST	NULL
CANCER	NULL
Acknowledgments	NULL
We	NULL
thank	NULL
Janos	NULL
Papp	NULL
and	NULL
Marco	NULL
van	NULL
der	NULL
Looij	NULL
for	NULL
excellent	NULL
technical	NULL
help	NULL
.	NULL

References	NULL
1	NULL
.	NULL

2	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

La	NULL
Vecchia	NULL
,	NULL
C.	NULL
,	NULL
Levi	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Lucchini	NULL
,	NULL
F.	NULL
Descriptive	NULL
epidemiology	NULL
of	NULL
male	NULL
breast	NULL
cancer	NULL
in	NULL
Europe	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
57	NULL
:	NULL
62-66	NULL
,	NULL
1992	NULL
.	NULL

Szabo	NULL
,	NULL
C.	NULL
I.	NULL
,	NULL
and	NULL
King	NULL
,	NULL
M-C	NULL
.	NULL

Inherited	NULL
breast	NULL
and	NULL
ovarian	NULL
cancer	NULL
.	NULL

Hum	NULL
.	NULL

Mol	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
4	NULL
:	NULL
1811-1817	NULL
,	NULL
1995.	NULL
.	NULL

Ford	NULL
,	NULL
D.	NULL
,	NULL
Easton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Stratton	NULL
,	NULL
M.	NULL
,	NULL
Narod	NULL
,	NULL
S.	NULL
,	NULL
Goldgar	NULL
,	NULL
D.	NULL
,	NULL
Devilee	NULL
,	NULL
P.	NULL
,	NULL
Bishop	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Weber	NULL
,	NULL
B.	NULL
,	NULL
Lenoir	NULL
,	NULL
G.	NULL
,	NULL
Chang-Claude	NULL
,	NULL
J.	NULL
,	NULL
Sobol	NULL
,	NULL
H.	NULL
,	NULL
Teare	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Stuewing	NULL
,	NULL
J.	NULL
,	NULL
Arason	NULL
,	NULL
A.	NULL
,	NULL
Scherneck	NULL
,	NULL
S.	NULL
,	NULL
Peto	NULL
,	NULL
J.	NULL
,	NULL
Rebbeck	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Tonin	NULL
,	NULL
P.	NULL
,	NULL
Neuhausen	NULL
,	NULL
S.	NULL
,	NULL
Barkardottir	NULL
,	NULL
R.	NULL
,	NULL
Eyfford	NULL
,	NULL
J.	NULL
,	NULL
Lynch	NULL
,	NULL
H.	NULL
,	NULL
Ponder	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
Gayther	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Birch	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Lindblom	NULL
,	NULL
A.	NULL
,	NULL
Stoppa-Lyonnet	NULL
,	NULL
D.	NULL
,	NULL
Bignon	NULL
,	NULL
Y.	NULL
,	NULL
Borg	NULL
,	NULL
A.	NULL
,	NULL
Hamann	NULL
,	NULL
U.	NULL
,	NULL
Haites	NULL
,	NULL
N.	NULL
,	NULL
Scott	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Maugard	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Vasen	NULL
,	NULL
H.	NULL
,	NULL
Seitz	NULL
,	NULL
S.	NULL
,	NULL
Cannon-Albright	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Schofield	NULL
,	NULL
A.	NULL
,	NULL
Zelada-Hedman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
the	NULL
Breast	NULL
Cancer	NULL
Linkage	NULL
Consortium	NULL
.	NULL

Genetic	NULL
heterogeneity	NULL
and	NULL
penetrance	NULL
analysis	NULL
of	NULL
the	NULL
BRCA	NULL
]	NULL
and	NULL
BRCA2	NULL
genes	NULL
in	NULL
breast	NULL
cancer	NULL
families	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
62	NULL
:	NULL
676-689	NULL
,	NULL
1998.	NULL
.	NULL

Wooster	NULL
,	NULL
R.	NULL
,	NULL
Bignell	NULL
,	NULL
G.	NULL
,	NULL
Lancaster	NULL
,	NULL
J.	NULL
,	NULL
Swift	NULL
,	NULL
S.	NULL
,	NULL
Seal	NULL
,	NULL
S.	NULL
,	NULL
Mangion	NULL
,	NULL
J.	NULL
,	NULL
Collins	NULL
,	NULL
N.	NULL
,	NULL
Gregory	NULL
,	NULL
S.	NULL
,	NULL
Gumbs	NULL
,	NULL
C.	NULL
,	NULL
Micklem	NULL
,	NULL
G.	NULL
,	NULL
Barfoot	NULL
,	NULL
R.	NULL
,	NULL
Hamoudi	NULL
,	NULL
R.	NULL
,	NULL
Patel	NULL
,	NULL
S.	NULL
,	NULL
Rice	NULL
,	NULL
C.	NULL
,	NULL
Biggs	NULL
,	NULL
P.	NULL
,	NULL
Hashim	NULL
,	NULL
Y.	NULL
,	NULL
Smith	NULL
,	NULL
A.	NULL
,	NULL
Connor	NULL
,	NULL
F.	NULL
,	NULL
Arason	NULL
,	NULL
A.	NULL
,	NULL
Gudmundsson	NULL
,	NULL
J.	NULL
,	NULL
Ficenec	NULL
,	NULL
D.	NULL
,	NULL
Kelsell	NULL
,	NULL
D.	NULL
,	NULL
Ford	NULL
,	NULL
D.	NULL
,	NULL
Tonin	NULL
,	NULL
P.	NULL
,	NULL
Bishop	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Spurr	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Ponder	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
Eeles	NULL
,	NULL
R.	NULL
,	NULL
Peto	NULL
,	NULL
J.	NULL
,	NULL
Devilee	NULL
,	NULL
P.	NULL
,	NULL
Cornelisse	NULL
,	NULL
C.	NULL
,	NULL
Lynch	NULL
,	NULL
H.	NULL
,	NULL
Narod	NULL
,	NULL
S.	NULL
,	NULL
Lenoir	NULL
,	NULL
G.	NULL
,	NULL
Egilsson	NULL
,	NULL
V.	NULL
,	NULL
Barkardottir	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Easton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Bentley	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Futreal	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ashworth	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Stratton	NULL
,	NULL
M.	NULL
R.	NULL
Identification	NULL
of	NULL
the	NULL
breast	NULL
cancer	NULL
susceptibility	NULL
gene	NULL
BRCAZ	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
378	NULL
:	NULL
789-792	NULL
,	NULL
1995.	NULL
.	NULL

Ramus	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Kote-Jarai	NULL
,	NULL
Z.	NULL
,	NULL
van	NULL
der	NULL
Looij	NULL
,	NULL
M.	NULL
,	NULL
Gayther	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Csokay	NULL
,	NULL
B.	NULL
,	NULL
Ponder	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
and	NULL
Olah	NULL
,	NULL
E.	NULL
Analysis	NULL
of	NULL
BRCA1	NULL
and	NULL
BRCAZ	NULL
mutations	NULL
in	NULL
Hungarian	NULL
families	NULL
with	NULL
breast	NULL
and	NULL
breast-ovarian	NULL
cancer	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
60	NULL
:	NULL
1242-1246	NULL
,	NULL
1997.	NULL
.	NULL

Anelli	NULL
,	NULL
A.	NULL
,	NULL
Anelli	NULL
,	NULL
T.	NULL
M.	NULL
F.	NULL
,	NULL
Youngson	NULL
,	NULL
B.	NULL
,	NULL
Rosen	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
and	NULL
Borgen	NULL
,	NULL
P.	NULL
I.	NULL
Mutations	NULL
of	NULL
the	NULL
p53	NULL
gene	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

Cancer	NULL
(	NULL
Phila	NULL
.	NULL
)	NULL

,	NULL
75	NULL
:	NULL
2233-2238	NULL
,	NULL
1995.	NULL
.	NULL

Lobaccaro	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Lumbroso	NULL
,	NULL
S.	NULL
,	NULL
Belon	NULL
,	NULL
C.	NULL
,	NULL
Galtier-Dereure	NULL
,	NULL
F.	NULL
,	NULL
Bringer	NULL
,	NULL
J.	NULL
,	NULL
Lesimple	NULL
,	NULL
T.	NULL
,	NULL
Namer	NULL
,	NULL
M.	NULL
,	NULL
Cutuli	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
Pujol	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Sultan	NULL
,	NULL
C.	NULL
Androgen	NULL
receptor	NULL
gene	NULL
mutation	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

Hum	NULL
.	NULL

Mol	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
2	NULL
:	NULL
1799-1802	NULL
,	NULL
1993.	NULL
.	NULL

Struewing	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Brody	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Erdos	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Kase	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Giambarresi	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Smith	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Detection	NULL
of	NULL
eight	NULL
BRCA1	NULL
mutations	NULL
in	NULL
10	NULL
breast/ovarian	NULL
cancer	NULL
families	NULL
,	NULL
including	NULL
1	NULL
family	NULL
with	NULL
male	NULL
breast	NULL
cancer	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
57	NULL
:	NULL
1-7	NULL
,	NULL
1995.	NULL
.	NULL

Hogervorst	NULL
,	NULL
F.	NULL
B.	NULL
L.	NULL
,	NULL
Cornelis	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Bout	NULL
,	NULL
M.	NULL
,	NULL
van	NULL
Vliet	NULL
,	NULL
M.	NULL
,	NULL
Oosterwijk	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Olmer	NULL
,	NULL
R.	NULL
,	NULL
Bakker	NULL
,	NULL
B.	NULL
,	NULL
Klijn	NULL
,	NULL
J.	NULL
G.	NULL
M.	NULL
,	NULL
Vasen	NULL
,	NULL
H.	NULL
F.	NULL
A.	NULL
,	NULL
Meijers-Heijboer	NULL
,	NULL
H.	NULL
,	NULL
Menk	NULL
,	NULL
F.	NULL
H.	NULL
,	NULL
Cornelisse	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
den	NULL
Dunnen	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Devilee	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
van	NULL
Ommen	NULL
,	NULL
G-J	NULL
.	NULL

B	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
BRCA1	NULL
mutations	NULL
by	NULL
the	NULL
protein	NULL
truncation	NULL
test	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
10	NULL
:	NULL
208-212	NULL
,	NULL
1995	NULL
.	NULL

Serova	NULL
,	NULL
O.	NULL
M.	NULL
,	NULL
Montagna	NULL
,	NULL
M.	NULL
,	NULL
Torchard	NULL
,	NULL
D.	NULL
,	NULL
Narod	NULL
,	NULL
S.	NULL
,	NULL
Tonin	NULL
,	NULL
P.	NULL
,	NULL
Sylla	NULL
,	NULL
B.	NULL
,	NULL
Lynch	NULL
,	NULL
H.	NULL
T.	NULL
,	NULL
Feunteun	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Lenoir	NULL
,	NULL
G.	NULL
M.	NULL
A	NULL
high	NULL
incidence	NULL
of	NULL
BRCA1	NULL
mutations	NULL
in	NULL
20	NULL
breast-ovarian	NULL
cancer	NULL
families	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
58	NULL
:	NULL
42-51	NULL
,	NULL
1996	NULL
.	NULL

Couch	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Farid	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
DeShano	NULL
,	NULL
M.	NULL
L..	NULL
,	NULL
Tavtigian	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
Calzone	NULL
,	NULL
K.	NULL
,	NULL
Campeau	NULL
,	NULL
L.	NULL
,	NULL
Peng	NULL
,	NULL
Y.	NULL
,	NULL
Bogden	NULL
,	NULL
B.	NULL
,	NULL
Chen	NULL
,	NULL
Q.	NULL
,	NULL
Neuhausen	NULL
,	NULL
S.	NULL
,	NULL
Shattuck-Eidens	NULL
,	NULL
D.	NULL
,	NULL
Godwin	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Daly	NULL
,	NULL
M.	NULL
,	NULL
Radford	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Sedlacek	NULL
,	NULL
S.	NULL
,	NULL
Rommens	NULL
,	NULL
J.	NULL
,	NULL
Simard	NULL
,	NULL
J.	NULL
,	NULL
Garber	NULL
,	NULL
J.	NULL
,	NULL
Merajver	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
B.	NULL
L.	NULL
BRCAZ	NULL
germline	NULL
mutations	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
cases	NULL
and	NULL
breast	NULL
cancer	NULL
families	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
13	NULL
:	NULL
123-125	NULL
,	NULL
1996	NULL
.	NULL

Phelan	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Lancaster	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Tonin	NULL
,	NULL
P.	NULL
,	NULL
Gumbs	NULL
,	NULL
C.	NULL
,	NULL
Cochran	NULL
,	NULL
C.	NULL
,	NULL
Carter	NULL
,	NULL
R.	NULL
,	NULL
Ghadirian	NULL
,	NULL
P.	NULL
,	NULL
Perret	NULL
,	NULL
C.	NULL
,	NULL
Moslehi	NULL
,	NULL
R.	NULL
,	NULL
Dion	NULL
,	NULL
F.	NULL
,	NULL
Faucher	NULL
,	NULL
M-C.	NULL
,	NULL
Dole	NULL
,	NULL
K.	NULL
,	NULL
Karimi	NULL
,	NULL
S.	NULL
,	NULL
Foulkes	NULL
,	NULL
W.	NULL
,	NULL
Lounis	NULL
,	NULL
H.	NULL
,	NULL
Warner	NULL
,	NULL
E.	NULL
,	NULL
Goss	NULL
,	NULL
P.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
,	NULL
Larsson	NULL
,	NULL
C.	NULL
,	NULL
Narod	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Futreal	NULL
,	NULL
P.	NULL
A.	NULL
Mutation	NULL
analysis	NULL
of	NULL
the	NULL
BRCAZ	NULL
gene	NULL
in	NULL
49	NULL
site-specific	NULL
breast	NULL
cancer	NULL
families	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
13	NULL
:	NULL
120-122	NULL
,	NULL
1996	NULL
.	NULL

Thorlacius	NULL
,	NULL
S.	NULL
,	NULL
Olafsdottir	NULL
,	NULL
G.	NULL
,	NULL
Tryggvadottir	NULL
,	NULL
L.	NULL
,	NULL
Neuhausen	NULL
,	NULL
S.	NULL
,	NULL
Jonasson	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Tavtigian	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
Tulinius	NULL
,	NULL
H.	NULL
,	NULL
Ogmundsdottir	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
Eyfjord	NULL
,	NULL
J.	NULL
E.	NULL
A	NULL
single	NULL
998	NULL
14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

BRCA2	NULL
mutation	NULL
in	NULL
male	NULL
and	NULL
female	NULL
breast	NULL
cancer	NULL
families	NULL
from	NULL
Iceland	NULL
with	NULL
varied	NULL
cancer	NULL
phenotypes	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
13	NULL
:	NULL
117-119	NULL
,	NULL
1996	NULL
.	NULL

Hoskins	NULL
,	NULL
K.	NULL
F.	NULL
,	NULL
Stopfer	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Calzone	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Merajver	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Rebbeck	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Garber	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
B.	NULL
L.	NULL
Assessment	NULL
and	NULL
counseling	NULL
for	NULL
women	NULL
with	NULL
a	NULL
family	NULL
history	NULL
of	NULL
breast	NULL
cancer	NULL
.	NULL

A	NULL
guide	NULL
for	NULL
clinicians	NULL
.	NULL

J	NULL
.	NULL

Am	NULL
.	NULL

Med	NULL
.	NULL

Assoc	NULL
.	NULL

,	NULL
273	NULL
:	NULL
577-585	NULL
,	NULL
1995	NULL
.	NULL

Meyskens	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
Jr.	NULL
,	NULL
Tormey	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
and	NULL
Neifeld	NULL
,	NULL
J.	NULL
P.	NULL
Male	NULL
breast	NULL
cancer	NULL
:	NULL
a	NULL
review	NULL
.	NULL

Cancer	NULL
Treat	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
3	NULL
:	NULL
83-93	NULL
,	NULL
1976	NULL
.	NULL

Cutuli	NULL
,	NULL
B.	NULL
,	NULL
Dilhuydy	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
De	NULL
Lafontan	NULL
,	NULL
B.	NULL
,	NULL
Berlie	NULL
,	NULL
J.	NULL
,	NULL
Lacroze	NULL
,	NULL
M.	NULL
,	NULL
Lesaunier	NULL
,	NULL
F.	NULL
,	NULL
Graic	NULL
,	NULL
Y.	NULL
,	NULL
Tortochaux	NULL
,	NULL
J.	NULL
,	NULL
Resbeut	NULL
,	NULL
M.	NULL
,	NULL
Lesimple	NULL
,	NULL
T.	NULL
,	NULL
Gamelin	NULL
,	NULL
E.	NULL
,	NULL
Campana	NULL
,	NULL
F.	NULL
,	NULL
Reme-Saumon	NULL
,	NULL
M.	NULL
,	NULL
Moncho-Bernier	NULL
,	NULL
V.	NULL
,	NULL
Cuilliere	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Marchal	NULL
,	NULL
C.	NULL
,	NULL
De	NULL
Gislain	NULL
,	NULL
G.	NULL
,	NULL
N'Guyen	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Teissier	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Velten	NULL
,	NULL
M.	NULL
Ductal	NULL
carcinoma	NULL
in	NULL
situ	NULL
of	NULL
the	NULL
male	NULL
breast	NULL
.	NULL

Analysis	NULL
of	NULL
31	NULL
cases	NULL
.	NULL

Bur	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
33	NULL
:	NULL
35-38	NULL
,	NULL
1997	NULL
.	NULL

Ramus	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Friedman	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Gayther	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Ponder	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
Bobrow	NULL
,	NULL
L.	NULL
,	NULL
van	NULL
der	NULL
Looij	NULL
,	NULL
M.	NULL
,	NULL
Papp	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Olah	NULL
,	NULL
E.	NULL
A	NULL
breast/ovarian	NULL
cancer	NULL
patient	NULL
with	NULL
germline	NULL
mutations	NULL
in	NULL
both	NULL
the	NULL
BRCA	NULL
]	NULL
and	NULL
BRCAZ	NULL
genes	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
15	NULL
:	NULL
14-15	NULL
,	NULL
1997	NULL
.	NULL

Tavtigian	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
Simard	NULL
,	NULL
J.	NULL
,	NULL
Rommens	NULL
,	NULL
J.	NULL
,	NULL
Couch	NULL
,	NULL
F.	NULL
,	NULL
Shattuck-Eidens	NULL
,	NULL
D.	NULL
,	NULL
Neuhausen	NULL
,	NULL
S.	NULL
,	NULL
Merajver	NULL
,	NULL
S.	NULL
,	NULL
Thorlacius	NULL
,	NULL
S.	NULL
,	NULL
Offit	NULL
,	NULL
K.	NULL
,	NULL
Stoppa-Lyonnet	NULL
,	NULL
D.	NULL
,	NULL
Belanger	NULL
,	NULL
C.	NULL
,	NULL
Bell	NULL
,	NULL
R.	NULL
,	NULL
Berry	NULL
,	NULL
S.	NULL
,	NULL
Bogden	NULL
,	NULL
R.	NULL
,	NULL
Chen	NULL
,	NULL
Q.	NULL
,	NULL
Davis	NULL
,	NULL
T.	NULL
,	NULL
Dumont	NULL
,	NULL
M.	NULL
,	NULL
Frye	NULL
,	NULL
C.	NULL
,	NULL
Hattier	NULL
,	NULL
T.	NULL
,	NULL
Jammulapati	NULL
,	NULL
S.	NULL
,	NULL
Janecki	NULL
,	NULL
T.	NULL
,	NULL
Jiang	NULL
,	NULL
P.	NULL
,	NULL
Kehrer	NULL
,	NULL
R.	NULL
,	NULL
Leblanc	NULL
,	NULL
J-F.	NULL
,	NULL
Mitchell	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
McArthur-Morrison	NULL
,	NULL
J.	NULL
,	NULL
Nguyen	NULL
,	NULL
K.	NULL
,	NULL
Peng	NULL
,	NULL
Y.	NULL
,	NULL
Samson	NULL
,	NULL
C.	NULL
,	NULL
Schroeder	NULL
,	NULL
M.	NULL
,	NULL
Snyder	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Steele	NULL
,	NULL
L..	NULL
,	NULL
Stringfellow	NULL
,	NULL
M.	NULL
,	NULL
Stroup	NULL
,	NULL
C.	NULL
,	NULL
Swedlund	NULL
,	NULL
B.	NULL
,	NULL
Swensen	NULL
,	NULL
J.	NULL
,	NULL
Teng	NULL
,	NULL
D.	NULL
,	NULL
Thomas	NULL
,	NULL
A.	NULL
,	NULL
Tran	NULL
,	NULL
T.	NULL
,	NULL
Tran	NULL
,	NULL
T.	NULL
,	NULL
Tranchant	NULL
,	NULL
M.	NULL
,	NULL
Weaver-Feldhaus	NULL
,	NULL
J.	NULL
,	NULL
Wong	NULL
,	NULL
A.	NULL
K.	NULL
C.	NULL
,	NULL
Shizuya	NULL
,	NULL
H.	NULL
,	NULL
Eyfjord	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Cannon-Albright	NULL
,	NULL
L.	NULL
,	NULL
Labrie	NULL
,	NULL
F.	NULL
,	NULL
Skolnick	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Weber	NULL
,	NULL
B.	NULL
,	NULL
Kamb	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Goldgar	NULL
,	NULL
D.	NULL
E.	NULL
The	NULL
complete	NULL
BRCA2	NULL
gene	NULL
and	NULL
mutations	NULL
in	NULL
chromosome	NULL
13q-linked	NULL
kindreds	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
12	NULL
;	NULL
333-337	NULL
,	NULL
1996	NULL
.	NULL

Serova	NULL
,	NULL
O.	NULL
M.	NULL
,	NULL
Boutrand	NULL
,	NULL
L.	NULL
,	NULL
Stoppa-Lyonnet	NULL
,	NULL
D.	NULL
,	NULL
Bressac-de-Paillerets	NULL
,	NULL
B.	NULL
,	NULL
Dubois	NULL
,	NULL
V.	NULL
,	NULL
Lasset	NULL
,	NULL
C.	NULL
,	NULL
Janin	NULL
,	NULL
N.	NULL
,	NULL
Bignon	NULL
,	NULL
Y.	NULL
,	NULL
Longy	NULL
,	NULL
M.	NULL
,	NULL
Maugard	NULL
,	NULL
C.	NULL
,	NULL
Lidereau	NULL
,	NULL
R.	NULL
,	NULL
Leroux	NULL
,	NULL
D.	NULL
,	NULL
Frebourg	NULL
,	NULL
T.	NULL
,	NULL
Mazoyer	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Lenoir	NULL
,	NULL
G.	NULL
M.	NULL
BRCAZ	NULL
mutations	NULL
in	NULL
hereditary	NULL
breast	NULL
and	NULL
ovarian	NULL
cancer	NULL
in	NULL
France	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
60	NULL
:	NULL
1236-1239	NULL
,	NULL
1997	NULL
.	NULL

Mavraki	NULL
,	NULL
E.	NULL
,	NULL
Gray	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
Bishop	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
and	NULL
Spurr	NULL
,	NULL
N.	NULL
K.	NULL
Germline	NULL
BRCAZ	NULL
mutations	NULL
in	NULL
men	NULL
with	NULL
breast	NULL
cancer	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
76	NULL
:	NULL
1428-1431	NULL
,	NULL
1997	NULL
.	NULL

Friedman	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Gayther	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Kurosaki	NULL
,	NULL
T.	NULL
,	NULL
Gordon	NULL
,	NULL
D.	NULL
,	NULL
Noble	NULL
,	NULL
B.	NULL
,	NULL
Casey	NULL
,	NULL
G.	NULL
,	NULL
Ponder	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
and	NULL
Anton-Culver	NULL
,	NULL
H.	NULL
Mutation	NULL
analysis	NULL
of	NULL
BRCA1	NULL
and	NULL
BRCA2	NULL
in	NULL
a	NULL
male	NULL
breast	NULL
cancer	NULL
population	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
60	NULL
:	NULL
313-319	NULL
,	NULL
1997	NULL
.	NULL

Haraldsson	NULL
,	NULL
K.	NULL
,	NULL
Loman	NULL
,	NULL
N.	NULL
,	NULL
Zhang	NULL
,	NULL
Q-X	NULL
.	NULL

,	NULL
Johannsson	NULL
,	NULL
O.	NULL
,	NULL
Olsson	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Borg	NULL
,	NULL
A.	NULL
BRCA2	NULL
germ-line	NULL
mutations	NULL
are	NULL
frequent	NULL
in	NULL
male	NULL
breast	NULL
cancer	NULL
patients	NULL
without	NULL
a	NULL
family	NULL
history	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
58	NULL
:	NULL
1367-1371	NULL
,	NULL
1998	NULL
.	NULL

Thorlacius	NULL
,	NULL
S.	NULL
,	NULL
Sigurdsson	NULL
,	NULL
S.	NULL
,	NULL
Bjarnadottir	NULL
,	NULL
H.	NULL
,	NULL
Olafsdottir	NULL
,	NULL
G.	NULL
,	NULL
Jonasson	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Trygevadottit	NULL
,	NULL
L.	NULL
,	NULL
Tulinius	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Eyfjord	NULL
,	NULL
J.	NULL
E.	NULL
Study	NULL
of	NULL
a	NULL
single	NULL
BRCA2	NULL
mutation	NULL
with	NULL
high	NULL
carrier	NULL
frequency	NULL
in	NULL
a	NULL
small	NULL
population	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
60	NULL
:	NULL
1079-1084	NULL
,	NULL
1997	NULL
.	NULL

Rosenblatt	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
McTicman	NULL
,	NULL
A.	NULL
,	NULL
Austin	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Stalsberg	NULL
,	NULL
H.	NULL
,	NULL
Stemhagen	NULL
,	NULL
A.	NULL
,	NULL
Thompson	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
Curnen	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Satariano	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Austin	NULL
,	NULL
D.	NULL
F.	NULL
Breast	NULL
cancer	NULL
in	NULL
men	NULL
:	NULL
aspects	NULL
of	NULL
familial	NULL
aggregation	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

,	NULL
83	NULL
:	NULL
849-854	NULL
,	NULL
1991	NULL
.	NULL

Donegan	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
and	NULL
Redlich	NULL
,	NULL
P.	NULL
N.	NULL
Breast	NULL
cancer	NULL
in	NULL
men	NULL
.	NULL

Surg	NULL
.	NULL

Clin	NULL
.	NULL

N	NULL
.	NULL

Am	NULL
.	NULL

,	NULL
76	NULL
:	NULL
343-363	NULL
,	NULL
1996	NULL
.	NULL

Neuhausen	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Godwin	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Gershoni-Baruch	NULL
,	NULL
R.	NULL
,	NULL
Schubert	NULL
,	NULL
E.	NULL
,	NULL
Garber	NULL
,	NULL
J.	NULL
,	NULL
Stoppa-Lyonnet	NULL
,	NULL
D.	NULL
,	NULL
Olah	NULL
,	NULL
E.	NULL
,	NULL
Csokay	NULL
,	NULL
B.	NULL
,	NULL
Serova	NULL
,	NULL
O.	NULL
,	NULL
Lalloo	NULL
,	NULL
F.	NULL
,	NULL
Osorio	NULL
,	NULL
A.	NULL
,	NULL
Stratton	NULL
,	NULL
M.	NULL
,	NULL
Offit	NULL
,	NULL
K.	NULL
,	NULL
Boyd	NULL
,	NULL
J.	NULL
,	NULL
Caligo	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Scott	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Schofield	NULL
,	NULL
A.	NULL
,	NULL
Teugels	NULL
,	NULL
E.	NULL
,	NULL
Schwab	NULL
,	NULL
M.	NULL
,	NULL
Cannon-Albright	NULL
,	NULL
L.	NULL
,	NULL
Bishop	NULL
,	NULL
T.	NULL
,	NULL
Easton	NULL
,	NULL
D.	NULL
,	NULL
Benitez	NULL
,	NULL
J.	NULL
,	NULL
King	NULL
,	NULL
M-C.	NULL
,	NULL
Ponder	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
Weber	NULL
,	NULL
B.	NULL
,	NULL
Devilee	NULL
,	NULL
P.	NULL
,	NULL
Borg	NULL
,	NULL
A.	NULL
,	NULL
Narod	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Goldgar	NULL
,	NULL
D.	NULL
Haplotype	NULL
and	NULL
phenotype	NULL
analysis	NULL
of	NULL
nine	NULL
recurrent	NULL
BRCA2	NULL
mutations	NULL
in	NULL
111	NULL
families	NULL
:	NULL
results	NULL
of	NULL
an	NULL
international	NULL
study	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
62	NULL
:	NULL
1381-1388	NULL
,	NULL
1998	NULL
.	NULL

Savelyeva	NULL
,	NULL
L.	NULL
,	NULL
Claas	NULL
,	NULL
A.	NULL
,	NULL
Gier	NULL
,	NULL
S.	NULL
,	NULL
Schlag	NULL
,	NULL
P.	NULL
,	NULL
Finke	NULL
,	NULL
L.	NULL
,	NULL
Mangion	NULL
,	NULL
J.	NULL
,	NULL
Stratton	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Schwab	NULL
,	NULL
M.	NULL
An	NULL
interstitial	NULL
tandem	NULL
duplication	NULL
of	NULL
9p23-24	NULL
coexist	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
BRCAZ	NULL
gene	NULL
in	NULL
the	NULL
germ	NULL
line	NULL
of	NULL
three	NULL
brothers	NULL
with	NULL
breast	NULL
cancer	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
58	NULL
:	NULL
863-866	NULL
,	NULL
1998	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
High	NULL
Frequency	NULL
of	NULL
Germ-Line	NULL
BRCAZ	NULL
Mutations	NULL
among	NULL
Hungarian	NULL
Male	NULL
Breast	NULL
Cancer	NULL
Patients	NULL
without	NULL
Family	NULL
History	NULL
Bela	NULL
Csokay	NULL
,	NULL
Nora	NULL
Udvarhelyi	NULL
,	NULL
Zoltan	NULL
Sulyok	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cancer	NULL
Res	NULL
1999	NULL
;	NULL
59:995-998	NULL
.	NULL

Updated	NULL
version	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/5/995	NULL
Cited	NULL
articles	NULL
Citing	NULL
articles	NULL
This	NULL
article	NULL
cites	NULL
25	NULL
articles	NULL
,	NULL
2	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/5/995	NULL
.full	NULL
#	NULL
ref-list-	NULL
1	NULL
This	NULL
article	NULL
has	NULL
been	NULL
cited	NULL
by	NULL
8	NULL
HighWire-hosted	NULL
articles	NULL
.	NULL

Access	NULL
the	NULL
articles	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/5/995	NULL
.full	NULL
#	NULL
related-urls	NULL
E-mail	NULL
alerts	NULL
Reprints	NULL
and	NULL
Subscriptions	NULL
Permissions	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/5/995	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

